Switching to TAF-based PrEP improves kidney and bone markers – but does it raise cardiovascular risk?

People who switched from Truvada (tenofovir disoproxil fumarate/emtricitabine) to the newer Descovy (tenofovir alafenamide/emtricitabine) for pre-exposure prophylaxis (PrEP) experienced improvements in measures of kidney function and bone density, but adverse clinical outcomes were rare with either coformulation, researchers reported at the recent IDWeek 2019 conference in Washington, DC. However, another study looking at HIV treatment… Read More »

What Banking Can Teach Health Care About Handling Customer Data – Harvard Business Review

Executive Summary Why can we run our entire financial lives with a few smartphone apps, a couple of plastic cards, and an ATM network, while so many of our interactions with the health care system still rely on phone calls, copiers, fax machines, and even the occasional multi-part form? Why is the routine exchange of… Read More »

Is There Treatment for Varicose Veins?

What Are Varicose Veins, and What Causes Them? Blood is meant to travel from your heart throughout your body via your veins. These veins have valves that open to let blood flow past and close off behind it. When these valves aren’t working correctly or become weak, blood is then backed up around the vein… Read More »